Annual Revenue:
$221.90M+$212.60M(+2285.27%)Summary
- As of today, BBIO annual revenue is $221.90 million, with the most recent change of +$212.60 million (+2285.27%) on December 31, 2024.
- During the last 3 years, BBIO annual revenue has risen by +$152.19 million (+218.29%).
- BBIO annual revenue is now at all-time high.
Performance
BBIO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Revenue:
$110.56M-$6.07M(-5.20%)Summary
- As of today, BBIO quarterly revenue is $110.56 million, with the most recent change of -$6.07 million (-5.20%) on June 30, 2025.
- Over the past year, BBIO quarterly revenue has increased by +$108.40 million (+4999.86%).
- BBIO quarterly revenue is now -47.63% below its all-time high of $211.12 million, reached on March 31, 2024.
Performance
BBIO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Revenue:
$235.81M+$108.40M(+85.07%)Summary
- As of today, BBIO TTM revenue is $235.81 million, with the most recent change of +$108.40 million (+85.07%) on June 30, 2025.
- Over the past year, BBIO TTM revenue has increased by +$16.69 million (+7.62%).
- BBIO TTM revenue is now at all-time high.
Performance
BBIO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BBIO Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +2285.3% | +4999.9% | +7.6% |
| 3Y3 Years | +218.3% | +49.9% | +160.1% |
| 5Y5 Years | +447.1% | +100.0% | +974.5% |
BBIO Revenue Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +2285.3% | -47.6% | >+9999.0% | at high | +4055.3% |
| 5Y | 5-Year | at high | +2590.1% | -47.6% | >+9999.0% | at high | +4055.3% |
| All-Time | All-Time | at high | >+9999.0% | -47.6% | >+9999.0% | at high | >+9999.0% |
BBIO Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $110.56M(-5.2%) | $235.81M(+85.1%) |
| Mar 2025 | - | $116.63M(+1882.9%) | $127.42M(-42.6%) |
| Dec 2024 | $221.90M(+2285.3%) | $5.88M(+115.3%) | $221.90M(+1.9%) |
| Sep 2024 | - | $2.73M(+26.0%) | $217.76M(-0.6%) |
| Jun 2024 | - | $2.17M(-99.0%) | $219.12M(+0.2%) |
| Mar 2024 | - | $211.12M(>+9900.0%) | $218.60M(+2249.7%) |
| Dec 2023 | $9.30M(-88.0%) | $1.75M(-57.3%) | $9.30M(-1.3%) |
| Sep 2023 | - | $4.09M(+149.3%) | $9.43M(+66.1%) |
| Jun 2023 | - | $1.64M(-10.1%) | $5.67M(-92.7%) |
| Mar 2023 | - | $1.83M(-2.4%) | $77.78M(+0.2%) |
| Dec 2022 | $77.65M(+11.4%) | $1.87M(+453.3%) | $77.65M(-12.4%) |
| Sep 2022 | - | $338.00K(-99.5%) | $88.66M(-2.2%) |
| Jun 2022 | - | $73.75M(+4253.4%) | $90.67M(+27.8%) |
| Mar 2022 | - | $1.69M(-86.9%) | $70.95M(+1.8%) |
| Dec 2021 | $69.72M | $12.89M(+449.7%) | $69.72M(+22.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $2.34M(-95.7%) | $56.95M(-9.2%) |
| Jun 2021 | - | $54.02M(>+9900.0%) | $62.73M(+620.2%) |
| Mar 2021 | - | $462.00K(+278.7%) | $8.71M(+5.6%) |
| Dec 2020 | $8.25M(-79.7%) | $122.00K(-98.5%) | $8.25M(-62.4%) |
| Sep 2020 | - | $8.13M(>+9900.0%) | $21.95M(-45.9%) |
| Jun 2020 | - | $0.00(0.0%) | $40.56M(0.0%) |
| Mar 2020 | - | $0.00(-100.0%) | $40.56M(0.0%) |
| Dec 2019 | $40.56M(>+9900.0%) | $13.82M(-48.3%) | $40.56M(+51.7%) |
| Sep 2019 | - | $26.74M(>+9900.0%) | $26.74M(>+9900.0%) |
| Jun 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | - | - |
| Sep 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
| Dec 2017 | $0.00 | - | - |
FAQ
- What is BridgeBio Pharma, Inc. annual revenue?
- What is the all-time high annual revenue for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual revenue year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly revenue?
- What is the all-time high quarterly revenue for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly revenue year-on-year change?
- What is BridgeBio Pharma, Inc. TTM revenue?
- What is the all-time high TTM revenue for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. TTM revenue year-on-year change?
What is BridgeBio Pharma, Inc. annual revenue?
The current annual revenue of BBIO is $221.90M
What is the all-time high annual revenue for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual revenue is $221.90M
What is BridgeBio Pharma, Inc. annual revenue year-on-year change?
Over the past year, BBIO annual revenue has changed by +$212.60M (+2285.27%)
What is BridgeBio Pharma, Inc. quarterly revenue?
The current quarterly revenue of BBIO is $110.56M
What is the all-time high quarterly revenue for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly revenue is $211.12M
What is BridgeBio Pharma, Inc. quarterly revenue year-on-year change?
Over the past year, BBIO quarterly revenue has changed by +$108.40M (+4999.86%)
What is BridgeBio Pharma, Inc. TTM revenue?
The current TTM revenue of BBIO is $235.81M
What is the all-time high TTM revenue for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high TTM revenue is $235.81M
What is BridgeBio Pharma, Inc. TTM revenue year-on-year change?
Over the past year, BBIO TTM revenue has changed by +$16.69M (+7.62%)